Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$2.32 - $3.86 $93,182 - $155,036
40,165 New
40,165 $141,000
Q4 2023

Feb 26, 2024

BUY
$0.54 - $1.82 $13,828 - $46,606
25,608 Added 163.85%
41,237 $70,000
Q3 2023

Nov 14, 2023

BUY
$0.97 - $1.8 $15,160 - $28,132
15,629 New
15,629 $16,000
Q2 2022

Aug 09, 2022

BUY
$2.3 - $6.29 $55,961 - $153,041
24,331 Added 55.84%
67,900 $189,000
Q1 2022

May 17, 2022

BUY
$4.63 - $9.94 $116,967 - $251,114
25,263 Added 138.0%
43,569 $249,000
Q4 2021

Feb 17, 2022

BUY
$8.35 - $12.6 $152,855 - $230,655
18,306 New
18,306 $167,000
Q1 2021

May 19, 2021

SELL
$14.49 - $20.72 $299,464 - $428,220
-20,667 Closed
0 $0
Q4 2020

Feb 24, 2021

BUY
$14.61 - $22.14 $301,944 - $457,567
20,667 New
20,667 $437,000
Q3 2020

Dec 11, 2020

SELL
$13.67 - $17.77 $534,920 - $695,357
-39,131 Closed
0 $0
Q2 2020

Aug 07, 2020

BUY
$10.89 - $21.47 $235,997 - $465,276
21,671 Added 124.12%
39,131 $576,000
Q4 2019

Feb 04, 2020

BUY
$17.42 - $26.61 $304,153 - $464,610
17,460 New
17,460 $410,000
Q4 2018

Jan 16, 2019

SELL
$22.03 - $32.01 $604,811 - $878,802
-27,454 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$30.0 - $40.85 $823,620 - $1.12 Million
27,454 New
27,454 $869,000
Q2 2018

Jul 30, 2018

SELL
$26.4 - $42.0 $252,938 - $402,402
-9,581 Closed
0 $0
Q2 2018

Jul 30, 2018

BUY
$26.4 - $42.0 $184 - $294
7 Added 0.07%
9,581 $372,000
Q1 2018

May 14, 2018

SELL
$18.43 - $28.8 $801,981 - $1.25 Million
-43,515 Reduced 81.97%
9,574 $264,000
Q4 2017

Feb 09, 2018

BUY
$14.8 - $18.85 $318,126 - $405,180
21,495 Added 68.04%
53,089 $961,000
Q3 2017

Nov 15, 2017

BUY
$14.65 - $16.85 $462,852 - $532,358
31,594
31,594 $1,000

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $138M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.